Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Transposon Therapeutics Inc.

United States 2765 Sand Hill Road, 94025-7098, United States

About the sponsor

Transposon Therapeutics Inc. focuses on clinical research in Aicardi-Goutières Syndrome, a rare inherited condition marked by abnormal activation of the innate immune system and chronic inflammatory signaling.

  • Aicardi-Goutières Syndrome
  • Interferon-mediated inflammation
  • Rare genetic neurological disorders

The sponsor’s current research interest is centered on understanding and addressing the inflammatory biology associated with this neurogenetic disorder.

About Specializations

Transposon Therapeutics Inc. runs clinical trials in conditions such as Aicardi-Goutieres syndrome, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Aicardi-Goutieres syndrome

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Censavudine
  • Sponsor:Transposon Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.